EconPapers    
Economics at your fingertips  
 

MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis

Chuanjiang Yu, Qiong Shen, Antony B. Holmes, Tongwei Mo, Anna Tosato, Rajesh Kumar Soni, Clarissa Corinaldesi, Sanjay Koul, Laura Pasqualucci, Shafinaz Hussein, Farhad Forouhar, Riccardo Dalla-Favera () and Katia Basso ()
Additional contact information
Chuanjiang Yu: Columbia University
Qiong Shen: Columbia University
Antony B. Holmes: Columbia University
Tongwei Mo: Columbia University
Anna Tosato: Columbia University
Rajesh Kumar Soni: Columbia University
Clarissa Corinaldesi: Columbia University
Sanjay Koul: Bayside
Laura Pasqualucci: Columbia University
Shafinaz Hussein: Icahn School of Medicine at Mount Sinai
Farhad Forouhar: Columbia University
Riccardo Dalla-Favera: Columbia University
Katia Basso: Columbia University

Nature Communications, 2024, vol. 15, issue 1, 1-19

Abstract: Abstract The myocyte enhancer factor 2B (MEF2B) transcription factor is frequently mutated in germinal center (GC)-derived B-cell lymphomas. Its ammino (N)-terminal mutations drive lymphomagenesis by escaping interaction with transcriptional repressors, while the function of carboxy (C)-terminal mutations remains to be elucidated. Here, we show that MEF2B C-tail is physiologically phosphorylated at specific residues and phosphorylation at serine (S)324 is impaired by lymphoma-associated mutations. Lack of phosphorylation at S324 enhances the interaction of MEF2B with the SWI/SNF chromatin remodeling complex, leading to higher transcriptional activity. In addition, these mutants show an increased protein stability due to impaired interaction with the CUL3/KLHL12 ubiquitin complex. Mice expressing a phosphorylation-deficient lymphoma-associated MEF2B mutant display GC enlargement and develop GC-derived lymphomas, when crossed with Bcl2 transgenic mice. These results unveil converging mechanisms of action for a diverse spectrum of MEF2B mutations, all leading to its dysregulation and GC B-cell lymphomagenesis.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-51644-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51644-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-51644-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51644-8